ubenimex has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, X; Ge, P; Wu, B; Zhang, P | 1 |
| Li, Y; Liu, XJ; Wu, SY; Zhen, YS; Zheng, YB | 1 |
| Ito, S; Miyahara, R; Nagai, S; Takahashi, R; Takenaka, K; Tanaka, F; Wada, H | 1 |
| DuBois, RN | 1 |
| Beer, DG; Chen, X; Hong, J; Jiao, X; Krasna, MJ; Li, N; Wang, S; Wu, N; Yang, CS | 1 |
| Abe, F; Horinishi, H; Ishizuka, M; Matsuda, A; Shibuya, K; Takahashi, K; Takeuchi, T; Uchida, M; Umezawa, H | 1 |
| Ashida, C; Gose, K; Hamada, F; Ichiyanagi, A; Imajo, Y; Imanaka, K; Inomata, Y; Kimura, S; Ogawa, Y; Takada, Y | 1 |
| Mishina, H; Okuyama, S | 2 |
| Dobashi, K; Ezawa, K; Minato, K | 1 |
| Kotake, Y; Nakano, N; Ohshima, S; Tominaga, S; Yasumitsu, T | 1 |
| Abe, F; Ashizawa, J; Horinishi, H; Ishizuka, M; Matsuda, A; Shibuya, K; Takahashi, K; Takeuchi, T; Umezawa, H | 1 |
1 trial(s) available for ubenimex and Adenocarcinoma
| Article | Year |
|---|---|
Bestatin in resected lung cancer. A randomized clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1990 |
11 other study(ies) available for ubenimex and Adenocarcinoma
| Article | Year |
|---|---|
Ubenimex Combined with Pemetrexed Upregulates SOCS1 to Inhibit Lung Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Humans; Janus Kinase 2; Leucine; Lung Neoplasms; Mice; Mice, Nude; Pemetrexed; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein | 2022 |
A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Dexamethasone; Dipyridamole; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured; Tumor Microenvironment; Vasodilator Agents; Xenograft Model Antitumor Assays | 2014 |
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; CD13 Antigens; Chemotherapy, Adjuvant; Female; Fibroblasts; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Leucine; Lung Neoplasms; Lymph Node Excision; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Pneumonectomy; Retrospective Studies; Time Factors; Treatment Outcome | 2009 |
Leukotriene A4 signaling, inflammation, and cancer.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Arachidonate 5-Lipoxygenase; Cell Transformation, Neoplastic; Cyclooxygenase Inhibitors; Disease Models, Animal; Epoxide Hydrolases; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Leucine; Leukotriene A4; Neoplasms; Signal Transduction; Up-Regulation | 2003 |
Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.
Topics: Adenocarcinoma; Anastomosis, Surgical; Animals; Antibiotics, Antineoplastic; Blotting, Western; Chemoprevention; Disease Models, Animal; Duodenum; Epoxide Hydrolases; Esophageal Neoplasms; Esophagus; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Incidence; Inflammation; Leucine; Leukotriene A4; Rats; Stomach; Treatment Outcome; Up-Regulation | 2003 |
Effect of bestatin on syngeneic tumors in mice.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antibody-Dependent Cell Cytotoxicity; Cell Line; Colonic Neoplasms; Killer Cells, Natural; Leucine; Leukemia, Myeloid; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Spleen | 1984 |
[Clinical evaluation of bestatin (NK-421) supplementing radiotherapy in the treatment of lung cancer].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage | 1983 |
Decrease in saturation density of mammalian carcinoma cell culture during exposure to bestatin, a clinically applicable agent.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Female; Leucine; Mammary Neoplasms, Experimental; Mice; Time Factors | 1984 |
Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Division; DNA Fragmentation; Humans; Leucine; Lung Neoplasms; Tumor Cells, Cultured | 1996 |
Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Female; Leucine; Mammary Neoplasms, Experimental; Mice; Prostaglandin D2; Prostaglandins D | 1985 |
Enhancement of antitumor effect of cytotoxic agents by bestatin.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Leucine; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Neoplasms, Experimental | 1985 |